@siusiu 智利三分之一人口、四百万人次在二月份就接种了中国科兴疫苗，现在迎来第二波更严重的新冠大爆发……
@kumano_1 @siusiu @rahuyana@unstable.icu 三個月後WSJ對印尼大量接種科興疫苗觀察:
"Indonesia is relying heavily on the Sinovac vaccine. The shot is approved by the World Health Organization for emergency use, but wide-ranging efficacy levels from different clinical trials and a lack of transparency about the data have led to concerns among some public-health experts about the degree of protection it provides as well as how long the protection lasts.
Its efficacy in preventing symptomatic infections was as low as around 50% in a study from Brazil, though the vaccine has shown higher efficacy in preventing severe Covid-19 cases. Authorities in Chile said in April the shot was 80% effective against death from Covid-19 two weeks after a second dose."
@kumano_1 @siusiu @rahuyana@unstable.icu 一星期後，印尼最終不得不決定打過兩劑科興的醫護人員補打莫德納作為亡羊補牢：
“印尼已購買1億850萬劑的中國科興疫苗，但完整接種2劑科興的醫護人員，染疫的人數仍持續增加。英國廣播公司（BBC）引述印尼一個醫護工會說法指出，今年2月至6月間，至少20名醫生和10名護士在完成接種科興疫苗後仍染疫死亡。
因此，衛生部長布迪（Budi Gunadi Sadikin）9日宣布，政府將讓全國147萬名醫護人員，每人再接種1劑莫德納疫苗，「只有醫護人員可以打第3針，因為醫護人員每天都接觸大量的病毒，必須不惜代價保護他們。」印尼政府日前已授權莫德納疫苗緊急使用。”
